Cargando…

LncRNA SNHG1 Facilitates Tumor Proliferation and Represses Apoptosis by Regulating PPARγ Ubiquitination in Bladder Cancer

SIMPLE SUMMARY: Our study elucidated that SNHG1 promotes MDM2 expression by binding to miR-9-3p to promote PPARγ ubiquitination and downregulate PPARγ expression and that SNHG1 plays an important role in bladder cancer and provides a potential therapeutic target for bladder cancer. ABSTRACT: Backgro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Hongzhou, Xu, Haifei, Lu, Hongcheng, Xu, Weizhang, Liu, Haofeng, Wang, Xinwei, Zhou, Guoren, Yang, Xuejian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562694/ https://www.ncbi.nlm.nih.gov/pubmed/36230661 http://dx.doi.org/10.3390/cancers14194740

Ejemplares similares

LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2
por: Lu, Wei, et al.
Publicado: (2021)

The value of urinary exosomal lncRNA SNHG16 as a diagnostic biomarker for bladder cancer
por: Liu, Chengyi, et al.
Publicado: (2023)

The prognostic value of lncRNA SNHG6 in cancer patients
por: Shen, Haixiang, et al.
Publicado: (2020)

Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer
por: Cai, Hongzhou, et al.
Publicado: (2019)

Down-regulation LncRNA-SNHG15 contributes to proliferation and invasion of bladder cancer cells
por: Mokhtar, Aldhabi, et al.
Publicado: (2021)

LncRNA SNHG3, a potential oncogene in human cancers
por: Xu, Bin, et al.
Publicado: (2020)

LncRNA SNHG6 role in clinicopathological parameters in cancers
por: Khan, Khushbukhat, et al.
Publicado: (2023)

Pharmacological Repression of PPARγ Promotes Osteogenesis
por: Marciano, David P., et al.
Publicado: (2015)

m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer
por: Li, Zuwei, et al.
Publicado: (2021)

LncRNA SNHG1: role in tumorigenesis of multiple human cancers
por: Zeng, Huang, et al.
Publicado: (2023)

LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c‐MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer
por: Xie, Jinbo, et al.
Publicado: (2022)

LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α
por: Xu, Linguo, et al.
Publicado: (2020)

lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition
por: Xu, Wenrui, et al.
Publicado: (2020)

lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition
por: Xu, Wenrui, et al.
Publicado: (2020)

Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer
por: Chen, Mingwei, et al.
Publicado: (2017)

LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy
por: Zhang, Peixian, et al.
Publicado: (2020)

lncRNA SNHG16 is associated with proliferation and poor prognosis of pediatric neuroblastoma
por: Yu, Yongbo, et al.
Publicado: (2019)

LncRNA SNHG15: A new budding star in human cancers
por: Shuai, You, et al.
Publicado: (2019)

lncRNA SNHG1 Promotes Basal Bladder Cancer Invasion via Interaction with PP2A Catalytic Subunit and Induction of Autophagy
por: Xu, Jiheng, et al.
Publicado: (2020)

LncRNA ACART protects cardiomyocytes from apoptosis by activating PPAR‐γ/Bcl‐2 pathway
por: Wu, Hao, et al.
Publicado: (2019)

LncRNA SNHG12 promotes cell growth and inhibits cell apoptosis in colorectal cancer cells
por: Wang, J.Z., et al.
Publicado: (2017)

Up-regulation of LncRNA SNHG20 Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Dongyan, et al.
Publicado: (2016)

The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis
por: Dong, Bingzi, et al.
Publicado: (2019)

LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
por: Xiao, Yuhang, et al.
Publicado: (2020)

LncRNA SNHG1 was down-regulated after menopause and participates in postmenopausal osteoporosis
por: Huang, Shuaihao, et al.
Publicado: (2019)

SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer
por: Tamang, Suraksha, et al.
Publicado: (2019)

The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer
por: Jiao, Yan, et al.
Publicado: (2020)

High expression of lncRNA-SNHG7 is associated with poor prognosis in hepatocellular carcinoma
por: Shen, An, et al.
Publicado: (2020)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma
por: Li, Xiao, et al.
Publicado: (2018)

The role and function of PPARγ in bladder cancer
por: Peng, Tianchen, et al.
Publicado: (2020)

LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR‐515‐5p/GINS2 axis
por: Dai, Guangcheng, et al.
Publicado: (2020)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018)

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
por: Lu, Chenfei, et al.
Publicado: (2020)

LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer
por: Li, Chao, et al.
Publicado: (2021)

lncRNA SNHG17 is Downregulated in Gestational Diabetes Mellitus (GDM) and Has Predictive Values
por: Li, Jingjun, et al.
Publicado: (2021)

Assessing the Regulatory Functions of LncRNA SNHG11 in Gastric Cancer Cell Proliferation and Migration
por: Zhao, Danyi, et al.
Publicado: (2021)

LncRNA SNHG6 Silencing Could Arrest Progression of High Grade Colorectal Cancers
por: Jafari-Oliayi, Amin, et al.
Publicado: (2022)

Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis
por: Zhang, Yunyuan, et al.
Publicado: (2022)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dip2gf27ap3i6oedn0a8vbcv7h